Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply

JAMA. 2023 Aug 1;330(5):471. doi: 10.1001/jama.2023.9366.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cholesterol, LDL
  • Coronary Artery Disease* / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Personality
  • Risk Factors
  • Treatment Outcome

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors